FDA recall D-66201-001

Hospira Inc. · Class II · drug

Product

5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Reason for recall

Presence of Particulate Matter; report of visible particulates in the glass ampule

Distribution

Nationwide

Key facts

Status: Terminated
Initiation date: 2013-08-29
Report date: 2013-10-09
Termination date: 2014-11-10
Voluntary/Mandated: Voluntary: Firm initiated
Location: Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-66201-001